-
05.23.2024 Convocation Notice of the 78th Ordinary General Meeting of Shareholders
(174KB)
読む Convocation Notice of the 78th Ordinary General Meeting of Shareholders
-
05.14.2024 Seikagaku Announces the Biologics License Application for SI-6603 Has Been Accepted for Filing by the U.S. FDA
(141KB)
-
05.13.2024 Consolidated Financial Results for the Fiscal Year Ended March 31, 2024
(384KB)
読む Consolidated Financial Results for the Fiscal Year Ended March 31, 2024
-
05.13.2024 Seikagaku Announces Differences between Full-Year Consolidated Financial Forecasts
(226KB)
読む Seikagaku Announces Differences between Full-Year Consolidated Financial Forecasts
Seikagaku News Releases are issued to provide stakeholders with the most up-to-date information related to our company.
-
06.21.2024 New Message from President & CEO
-
05.16.2024 Presentation Material for the Briefing on FY2023 Financial Results
読む Presentation Material for the Briefing on FY2023 Financial Results
-
05.13.2024 Seikagaku announced the financial results for the Fiscal Year ended March, 2024
読む Seikagaku announced the financial results for the Fiscal Year ended March, 2024
-
04.01.2024 Seikagaku will announce the financial results for the Fiscal Year ended March 31, 2024 at 16:00 on May 13, 2024